Organ Function Assays - Medical Devices Pipeline Assessment, 2019

Organ Function Assays - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Assessment, 2019 provides an overview of Organ Function Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Organ Function Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Organ Function Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date


  • Introduction
    • Organ Function Assays Overview
  • Products under Development
    • Organ Function Assays - Pipeline Products by Stage of Development
      • Table Figure 1: Organ Function Assays - Pipeline Products by Stage of Development
      • Table Organ Function Assays - Pipeline Products by Stage of Development
    • Organ Function Assays - Pipeline Products by Territory
      • Table Figure 2: Organ Function Assays - Pipeline Products by Territory
      • Table Organ Function Assays - Pipeline Products by Territory
    • Organ Function Assays - Pipeline Products by Regulatory Path
      • Table Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path
      • Table Organ Function Assays - Pipeline Products by Regulatory Path
    • Organ Function Assays - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
      • Table Organ Function Assays - Pipeline Products by Estimated Approval Date
    • Organ Function Assays - Ongoing Clinical Trials
      • Table Figure 5: Organ Function Assays - Ongoing Clinical Trials
      • Table Organ Function Assays - Ongoing Clinical Trials
  • Organ Function Assays - Pipeline Products under Development by Companies
    • Organ Function Assays Companies - Pipeline Products by Stage of Development
      • Table Organ Function Assays Companies - Pipeline Products by Stage of Development
    • Organ Function Assays - Pipeline Products by Stage of Development
      • Table Organ Function Assays - Pipeline Products by Stage of Development
  • Organ Function Assays Companies and Product Overview
    • Boditech Med Inc Company Overview
      • Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AFIAS-6 - Cystatin C Test - Product Status
        • Table AFIAS-6 - Cystatin C Test - Product Description
    • China Medical Technologies Inc (Inactive) Company Overview
      • China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Alpha 1-Microglobulin - Product Status
        • Table Diagnostic Assay - Alpha 1-Microglobulin - Product Description
        • Table Diagnostic Assay - ß2-Microglobulin - Product Status
        • Table Diagnostic Assay - ß2-Microglobulin - Product Description
        • Table Diagnostic Assay - Urea Albumin - Product Status
        • Table Diagnostic Assay - Urea Albumin - Product Description
    • Cornell University Company Overview
      • Cornell University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cornell University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Kidney Allograft Dysfunction - Product Status
        • Table Diagnostic Test - Kidney Allograft Dysfunction - Product Description
    • Daxor Corp Company Overview
      • Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table BVA-100 Glomerular Filtration Rate - Product Status
        • Table BVA-100 Glomerular Filtration Rate - Product Description
    • DSX Therapeutics LLC Company Overview
      • DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Transplant And Graft Rejection - Product Status
        • Table Diagnostic Test - Transplant And Graft Rejection - Product Description
    • French National Institute of Health and Medical Research Company Overview
      • French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kidney Transplant Rejection Assay - Product Status
        • Table Kidney Transplant Rejection Assay - Product Description
    • HepQuant Llc Company Overview
      • HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
        • Table HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
        • Table HepQuant-Dual - Product Status
        • Table HepQuant-Dual - Product Description
        • Table HepQuant-FLOW - Product Status
        • Table HepQuant-FLOW - Product Description
        • Table HepQuant-SHUNT - Product Status
        • Table HepQuant-SHUNT - Product Description
        • Table HepQuant-STAT - Product Status
        • Table HepQuant-STAT - Product Description
        • Table HepQuant Llc - Ongoing Clinical Trials Overview
        • Table HepQuant-Dual - Development of a Reliable Means for Functional Assessment of Liver Performance after the Fontan Operation: Dual Cholate Clearance Assay
        • Table HepQuant-SHUNT - Intra-individual Reproducibility of the Non-invasive Assessment of the Portal Circulation
        • Table HepQuant-SHUNT - The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
        • Table HepQuant-SHUNT - The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology
    • Humedics GmbH Company Overview
      • Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table LiMAx Test - Product Status
        • Table LiMAx Test - Product Description
    • Merck Millipore Corp Company Overview
      • Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kidney Toxicity Biomarker Test - Product Status
        • Table Kidney Toxicity Biomarker Test - Product Description
    • Myriad Genetics Inc Company Overview
      • Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Kidney Damage - Product Status
        • Table Diagnostic Test - Kidney Damage - Product Description
    • Proteome Sciences Plc Company Overview
      • Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Acute Liver Failure - Product Status
        • Table Biomarker Test - Acute Liver Failure - Product Description
    • Radboud University Medical Centre Company Overview
      • Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
        • Table Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renal Toxicity Screening Assay - Product Status
        • Table Renal Toxicity Screening Assay - Product Description
    • Schnellgen, Inc Company Overview
      • Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quantitative High-throughput Assay - Nephrotoxicity - Product Status
        • Table Quantitative High-throughput Assay - Nephrotoxicity - Product Description
  • Organ Function Assays- Recent Developments
    • Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters
    • Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members
    • Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
    • Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors
    • Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results
    • Aug 01, 2019: CareDx reports second quarter 2019 results
    • Jul 29, 2019: Siemens Healthineers continues to drive growth forward
    • Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
    • Jul 02, 2019: Grace Colon succeeds Amy Abernethy on the CareDx Board
    • May 08, 2019: CareDx reports first quarter 2019 results
    • May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results
    • May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
    • Apr 04, 2019: HepQuant's Disease Severity Index (DSI) demonstrates hepatic functional improvement in high percentage of NASH patients treated with obeticholic acid: Results from INTERCEPT 747-117
    • Mar 06, 2019: CareDx reports fourth quarter and FY 2018 results
    • Mar 04, 2019: Daxor Announces Rise in Kit Sales and Files Form N-CSR For 2018
    • Feb 20, 2019: Keith Hoffman joins HepQuant as Clinical Lab Manager
    • Feb 14, 2019: First patient enrolled in a pivotal trial of the HepQuant SHUNT Liver Diagnostic Test
    • Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
    • Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results
    • Jan 23, 2019: Proteome Sciences: Year-end trading update
    • Jan 07, 2019: CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
    • Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away
    • Dec 17, 2018: CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA
    • Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
    • Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed
    • Nov 26, 2018: CareDx names Reginald Seeto, MB.BS, as president and chief business officer
    • Nov 26, 2018: CareDx strengthens executive leadership team with the appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer
    • Nov 09, 2018: HepQuant receives IDE approval from U.S. FDA to initiate clinical trial of the SHUNT Liver Diagnostic Kit
    • Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members
    • Nov 08, 2018: CareDx reports third quarter results
    • Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status
    • Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook